chr11-62664891-A-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024099.5(LBHD1):c.621T>A(p.Asp207Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00000252 in 1,590,076 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Consequence
LBHD1
NM_024099.5 missense
NM_024099.5 missense
Scores
2
15
Clinical Significance
Conservation
PhyloP100: 4.76
Genes affected
LBHD1 (HGNC:28351): (LBH domain containing 1) This gene shares three exons in common with another gene, chromosome 11 open reading frame 98 (GeneID:102288414), but the encoded protein uses a reading frame that is different from that of the chromosome 11 open reading frame 98 gene. [provided by RefSeq, Nov 2017]
C11orf98 (HGNC:51238): (chromosome 11 open reading frame 98) This gene shares three exons in common with another gene, LBH domain containing 1 (GeneID:79081), but the encoded protein uses a reading frame that is different from that of the LBH domain containing 1 gene. [provided by RefSeq, Nov 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.093317926).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LBHD1 | NM_024099.5 | c.621T>A | p.Asp207Glu | missense_variant | 5/7 | ENST00000354588.8 | NP_077004.2 | |
C11orf98 | NM_001286086.2 | c.122T>A | p.Ile41Lys | missense_variant | 2/4 | ENST00000524958.6 | NP_001273015.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LBHD1 | ENST00000354588.8 | c.621T>A | p.Asp207Glu | missense_variant | 5/7 | 1 | NM_024099.5 | ENSP00000346600.3 | ||
C11orf98 | ENST00000524958.6 | c.122T>A | p.Ile41Lys | missense_variant | 2/4 | 2 | NM_001286086.2 | ENSP00000432523.2 | ||
ENSG00000255432 | ENST00000528405.1 | c.122T>A | p.Ile41Lys | missense_variant | 2/4 | 4 | ENSP00000435188.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152122Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
2
AN:
152122
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000959 AC: 2AN: 208604Hom.: 0 AF XY: 0.0000177 AC XY: 2AN XY: 112824
GnomAD3 exomes
AF:
AC:
2
AN:
208604
Hom.:
AF XY:
AC XY:
2
AN XY:
112824
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000139 AC: 2AN: 1437836Hom.: 0 Cov.: 31 AF XY: 0.00000140 AC XY: 1AN XY: 713136
GnomAD4 exome
AF:
AC:
2
AN:
1437836
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
713136
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152240Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74428
GnomAD4 genome
AF:
AC:
2
AN:
152240
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
74428
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 19, 2024 | The c.621T>A (p.D207E) alteration is located in exon 5 (coding exon 4) of the LBHD1 gene. This alteration results from a T to A substitution at nucleotide position 621, causing the aspartic acid (D) at amino acid position 207 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
.;T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
PROVEAN
Uncertain
D;D;D;.
REVEL
Benign
Sift
Benign
T;T;T;.
Sift4G
Benign
T;T;T;.
Polyphen
B;.;B;.
Vest4
MutPred
Gain of methylation at R210 (P = 0.1503);.;Gain of methylation at R210 (P = 0.1503);.;
MVP
MPC
0.13
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at